Wuhan Keqian Biology Co.,Ltd (SHA:688526)
China · Delayed Price · Currency is CNY 14.58
-0.12 (-0.82%)
Mar 30, 2026, 1:44 PM CST
SHA:688526 Market Cap
SHA:688526 has a market cap or net worth of 6.82 billion as of March 27, 2026. Its market cap has increased by 3.20% in one year.
Market Cap
6.82B
Enterprise Value
5.11B
Revenue
950.29M
Ranking
n/a
PE Ratio
16.33
Stock Price
14.58
Market Cap Chart
Since September 22, 2020, SHA:688526's market cap has decreased from 14.68B to 6.82B, a decrease of -53.56%. That is a compound annual growth rate of -12.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 6.82B | -3.67% |
| Dec 31, 2025 | 7.08B | 6.68% |
| Dec 31, 2024 | 6.64B | -30.15% |
| Dec 29, 2023 | 9.50B | -9.03% |
| Dec 30, 2022 | 10.44B | -18.45% |
| Dec 31, 2021 | 12.81B | -33.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Youcare Pharmaceutical Group | 7.85B |
| Nanjing Vazyme Biotech | 7.72B |
| Suzhou Fengbei Biotech Stock | 7.38B |
| Anhui Huaheng Biotechnology | 7.38B |
| Chengdu Kanghua Biological Products | 7.35B |
| Acrobiosystems | 7.09B |
| Jiangsu Aidea Pharmaceutical Group | 6.74B |
| Shenzhen Weiguang Biological Products | 6.24B |